Homepage
Open in app
Sign inGet started

Molecule Blog

An open source ecosystem to fund discovery of molecules and accelerate innovation. https://molecule.to/

  • Blockchain
  • Pharma
  • Product
  • Impact
  • Website
  • Introducing IP Tokens (IPTs): A New Incentive for Scientific Collaboration

    Introducing IP Tokens (IPTs): A New Incentive for Scientific Collaboration

    “Show me the incentive and I’ll show you the outcome” — Charlie Munger
    Go to the profile of Tyler Golato
    Tyler Golato
    Jul 11, 2023
    BioDAOs are Community-Owned Research Translation Engines, Not Investment DAOs

    BioDAOs are Community-Owned Research Translation Engines, Not Investment DAOs

    Moving research from concept to market is like conducting a symphony — there are numerous players and stakeholders, each bringing their…
    Go to the profile of Molecule
    Molecule
    Mar 17, 2023
    IP-NFTs: Everything you need to know as a developer

    IP-NFTs: Everything you need to know as a developer

    Intellectual Property NFTs are building blocks that power research DAOs in the DeSci ecosystem.
    Go to the profile of Stefan Adolf
    Stefan Adolf
    Jan 18, 2023
    The Scientific Singularity: Our Vision for The Future of Research with IP-NFTs

    The Scientific Singularity: Our Vision for The Future of Research with IP-NFTs

    The future of research is collaborative, digital, and highly autonomous. Patents today are not. We are building the intellectual property…
    Go to the profile of Heinrich
    Heinrich
    Dec 23, 2022
    The Emergence of Biotech DAOs

    The Emergence of Biotech DAOs

    A blossoming Decentralized Science (DeSci) movement is changing the biopharma landscape by enabling the formation of patient- and…
    Go to the profile of Tyler Golato
    Tyler Golato
    Jan 28, 2022
    IP-NFTs for Researchers: A New Biomedical Funding Paradigm

    IP-NFTs for Researchers: A New Biomedical Funding Paradigm

    TL;DR: This week, the first university biomedical intellectual property (IP) and research project was funded as an NFT (non-fungible…
    Go to the profile of Tyler Golato
    Tyler Golato
    Aug 19, 2021
    Announcing the first biopharma IPNFT Transaction

    Announcing the first biopharma IPNFT Transaction

    Funding the first longevity research project via utilizing intellectual property NFTs in the pharmaceutical space
    Go to the profile of clepp
    clepp
    Aug 13, 2021
    Molecule’s Biopharma IPNFTs — A Technical Description

    Molecule’s Biopharma IPNFTs — A Technical Description

    Enabling researchers to tokenize early-stage biopharma assets via the newly created intellectual property NTFs (IPNFT).
    Go to the profile of clepp
    clepp
    Aug 6, 2021
    An Open Bazaar for Drug Development: Molecule Protocol

    An Open Bazaar for Drug Development: Molecule Protocol

    Imagine a world where patients directly fund researchers developing the next therapeutic breakthrough they need. One where drug development…
    Go to the profile of Paul Kohlhaas
    Paul Kohlhaas
    Jun 11, 2021
    Molecule and the Search for Longevity Therapeutics

    Molecule and the Search for Longevity Therapeutics

    In a few short weeks, we will be launching one of our flagship longevity projects with the University of Copenhagen’s Center for Healthy…
    Go to the profile of Tyler Golato
    Tyler Golato
    Sep 30, 2020
    Reinventing Pharma Amidst Covid-19: From Siloes to Ecosystems

    Reinventing Pharma Amidst Covid-19: From Siloes to Ecosystems

    We are currently facing one of the largest healthcare crises in modern history — and it’s far from over. The hunt for cures and vaccines…
    Go to the profile of Paul Kohlhaas
    Paul Kohlhaas
    Apr 26, 2020
    The Impact of COVID-19 on Science, Publishing, and Drug Development

    The Impact of COVID-19 on Science, Publishing, and Drug Development

    The Defining Event of Our Lifetimes
    Go to the profile of Tyler Golato
    Tyler Golato
    Apr 24, 2020
    Molecule and Arctoris announce partnership to tackle the innovation crisis in drug development.

    Molecule and Arctoris announce partnership to tackle the innovation crisis in drug development.

    The pharmaceutical industry is facing a wide variety of challenges, but perhaps the most pressing is the ongoing innovation crisis. Drug…
    Go to the profile of Tyler Golato
    Tyler Golato
    Feb 10, 2020
    Molecule dives into Ocean

    Molecule dives into Ocean

    Ocean Data Economy Challenge: Molecule Dataswap
    Go to the profile of Benjamin Scholtz
    Benjamin Scholtz
    Jan 21, 2020
    Launching Molecule Catalyst

    Launching Molecule Catalyst

    A decentralized platform to fund the next therapeutic breakthrough
    Go to the profile of Titian Steiger
    Titian Steiger
    Jan 19, 2020
    Evolution not Revolution

    Evolution not Revolution

    Development of the brand for the Molecule Protocol
    Go to the profile of Michal Shachman
    Michal Shachman
    Dec 4, 2019
    About Molecule BlogLatest StoriesArchiveAbout MediumTermsPrivacyTeams